Acadia Healthcare Company, Inc.
ACHCHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeAcadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. At a $2.93B market cap, Acadia Healthcare Company, Inc. ranks as a mid-cap company within healthcare. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Market Cap
$2.93B
Beta
0.63
P/E (TTM)
—
P/E (Fwd)
17.06
EPS (TTM)
$-12.42
EPS (Fwd)
$1.85
ROE
-41.4%
ROA
3.6%
Cash
$171.3M
Total Debt
$2.59B
Free CF
-$105.0M
52W Change
37.3%
Annual Financials
Cash vs Debt
Where ACHC stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, ACHC finished 14.91% above its 150-day moving average ($27.56) and 27.80% above its 200-day moving average ($24.78). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ACHC overbought or oversold?
At the October 15, 2026 close, ACHC's RSI(14) was 74.3, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, ACHC has $171.3M in cash with $2.59B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$105.0M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -41.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $2.61B (2022) to $3.31B (2025), reflecting a 27% increase over the period.
The relatively low beta of 0.62 suggests ACHC is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing ACHC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.